Cholesterol medications linked to lower cancer-related deaths in women

Credit: CC0 Public Domain

Among women with breast cancer, colorectal cancer, or melanoma, those who were taking cholesterol-lowering medications, were less likely to die from cancer, according to an analysis published in the British Journal of Clinical Pharmacology.

The analysis included 20,046,11,719 and 6,430 women in Australia who were diagnosed with , , and melanoma, respectively, from 2003 to 2013. The women had been prescribed cholesterol-lowering medications such as statins before their diagnosis.

The more consistently women took these medications in the year after being diagnosed with cancer, the lower their likelihood of dying from the disease, suggesting that the drugs may have anti-tumor effects.

"If this inverse adherence-response relationship is confirmed, cholesterol-lowering medications—primarily statins—could be repurposed as to improve cancer prognosis," said co-author Jia-Li Feng, BMed, MMed, Ph.D., of QIMR Berghofer Medical Research Institute.

Explore further

Statins may reduce cancer risk through mechanisms separate to cholesterol

More information: Jia‐Li Feng et al, Does adherence to lipid‐lowering medications improve cancer survival? A nationwide study of breast and colorectal cancer, and melanoma, British Journal of Clinical Pharmacology (2020). DOI: 10.1111/bcp.14573
Provided by Wiley
Citation: Cholesterol medications linked to lower cancer-related deaths in women (2020, October 21) retrieved 2 December 2021 from
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Feedback to editors